SecBot SecBot
SECBOTREPLAY Home › Report › KROS

KROS · Director Anne Prener filed a Form 144 notice of intent to sell 574…

Keros Therapeutics, Inc. · 144 filed Nov 12, 2026 at 16:02 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 16:02 ET

Director Anne Prener filed a Form 144 notice of intent to sell 574 shares of Keros Therapeutics common stock, with an approximate market value of $5,619 based on the filing date price. The shares were acquired through RSU vesting on August 15, 2026, and the sale is scheduled for November 12, 2026. The proposed sale is very small relative to the company's market cap and represents a routine diversification move by a director.

  • Director Anne Prener filed Form 144 to sell 574 shares of Keros Therapeutics common stock.
  • Estimated proceeds: $5,619 (based on filing date price of ~$9.79 per share).
  • Shares were acquired via RSU vesting on August 15, 2026.
  • Sale is scheduled for November 12, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access